Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Free to Feed is a biotechnology company dedicated to supporting breastfeeding families navigating infant food allergies and sensitivities. The company is developing the first at-home diagnostic test strips designed to detect specific allergens, such as cow's milk protein and soy, within breast milk. By providing parents with real-time data on the presence of triggers, Free to Feed aims to reduce unnecessary dietary restrictions and empower mothers to continue breastfeeding. In addition to diagnostics, the company offers educational resources, personalized consultations, and a digital app to track infant symptoms and maternal diet. The company's mission is to provide scientific clarity to parents during the stressful period of managing infant reactivity. Free to Feed's technology utilizes advanced immunoassays to identify protein concentrations that cause allergic responses in sensitive infants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Free to Feed.